Qisda Croissance future
Future contrôle des critères 3/6
Qisda devrait augmenter ses bénéfices et ses revenus de 40.7% et de 4.5% par an respectivement, tandis que le BPA devrait croître de croître de 41.5% par an.
Informations clés
40.7%
Taux de croissance des bénéfices
41.48%
Taux de croissance du BPA
| Tech croissance des bénéfices | 26.1% |
| Taux de croissance des recettes | 4.5% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 24 Aug 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour du récit • Jun 26
2352: Higher Discount Rate And Compressed P/E Will Shape A Fair Outlook
Analysts have revised their price target for Qisda to NT$33.20 from NT$41.46, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Qisda No recent Qisda specific news items were identified in the provided sources.
Mise à jour du récit • Jun 11
2352: Refined Assumptions And Lower Multiple Will Shape Future Upside Potential
Analysts have trimmed their price target on Qisda to NT$32.60 from about NT$36.73, reflecting updated assumptions that combine a slightly higher discount rate and revised expectations for revenue growth, profit margin, and future P/E. What's in the News No recent news items or key developments were provided for Qisda, so there are currently no specific events to highlight from the supplied sources.Mise à jour du récit • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Mise à jour du récit • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Mise à jour du récit • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Mise à jour du récit • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Nouveau récit • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Mise à jour du récit • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Mise à jour du récit • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Mise à jour du récit • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Mise à jour du récit • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Mise à jour du récit • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Mise à jour du récit • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Mise à jour du récit • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Mise à jour du récit • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Mise à jour du récit • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Mise à jour du récit • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Mise à jour du récit • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
Nouveau récit • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Article d’analyse • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Article d’analyse • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Article d’analyse • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2027 | 223,311 | 2,373 | N/A | 12,314 | 2 |
| 12/31/2026 | 213,189 | 1,840 | N/A | 22,797 | 2 |
| 6/30/2026 | 208,965 | 1,215 | -1,650 | 3,549 | N/A |
| 3/31/2026 | 209,699 | 977 | -1,580 | 3,687 | N/A |
| 12/31/2025 | 207,905 | 1,143 | 3,313 | 9,106 | N/A |
| 9/30/2025 | 209,844 | 1,281 | 3,126 | 8,900 | N/A |
| 6/30/2025 | 208,105 | 2,083 | 22 | 5,721 | N/A |
| 3/31/2025 | 204,499 | 2,390 | -311 | 5,367 | N/A |
| 12/31/2024 | 201,666 | 2,164 | -2,480 | 3,301 | N/A |
| 9/30/2024 | 198,233 | 2,399 | -2,058 | 3,673 | N/A |
| 6/30/2024 | 197,809 | 2,548 | -793 | 4,615 | N/A |
| 3/31/2024 | 200,063 | 2,909 | 1,328 | 7,123 | N/A |
| 12/31/2023 | 203,595 | 2,976 | 8,276 | 13,611 | N/A |
| 9/30/2023 | 209,045 | 2,922 | 16,446 | 22,534 | N/A |
| 6/30/2023 | 218,734 | 8,084 | 12,293 | 18,883 | N/A |
| 3/31/2023 | 229,417 | 8,042 | 2,746 | 9,024 | N/A |
| 12/31/2022 | 239,837 | 8,252 | -8,195 | -1,191 | N/A |
| 9/30/2022 | 245,593 | 8,876 | -15,082 | -7,758 | N/A |
| 6/30/2022 | 242,734 | 3,907 | -16,648 | -9,963 | N/A |
| 3/31/2022 | 235,923 | 6,730 | -12,280 | -5,105 | N/A |
| 12/31/2021 | 225,961 | 8,308 | -4,599 | 2,115 | N/A |
| 9/30/2021 | 221,223 | 9,073 | -4,171 | 2,174 | N/A |
| 6/30/2021 | 215,716 | 9,724 | 4,015 | 10,595 | N/A |
| 3/31/2021 | 203,405 | 6,868 | 7,648 | 13,242 | N/A |
| 12/31/2020 | 191,702 | 4,988 | 9,613 | 14,569 | N/A |
| 9/30/2020 | 180,430 | 3,861 | 7,961 | 11,683 | N/A |
| 6/30/2020 | 171,539 | 2,825 | 8,624 | 11,687 | N/A |
| 3/31/2020 | 169,101 | 2,918 | N/A | 11,709 | N/A |
| 12/31/2019 | 169,754 | 3,575 | N/A | 8,475 | N/A |
| 9/30/2019 | 166,279 | 3,981 | N/A | 6,572 | N/A |
| 6/30/2019 | 163,148 | 4,166 | N/A | 7,005 | N/A |
| 3/31/2019 | 159,983 | 3,927 | N/A | 7,073 | N/A |
| 12/31/2018 | 155,783 | 4,035 | N/A | 8,958 | N/A |
| 9/30/2018 | 150,516 | 4,412 | N/A | 8,414 | N/A |
| 6/30/2018 | 146,001 | 4,497 | N/A | 7,913 | N/A |
| 3/31/2018 | 140,830 | 5,058 | N/A | 4,389 | N/A |
| 12/31/2017 | 136,862 | 5,291 | N/A | 336 | N/A |
| 9/30/2017 | 134,025 | 5,475 | N/A | 4,681 | N/A |
| 6/30/2017 | 130,853 | 5,626 | N/A | 2,228 | N/A |
| 3/31/2017 | 129,476 | 5,059 | N/A | 5,254 | N/A |
| 12/31/2016 | 129,554 | 4,342 | N/A | 7,948 | N/A |
| 9/30/2016 | 129,484 | 2,998 | N/A | 7,144 | N/A |
| 6/30/2016 | 130,750 | 2,141 | N/A | 6,600 | N/A |
| 3/31/2016 | 132,439 | 2,063 | N/A | 7,470 | N/A |
| 12/31/2015 | 133,102 | 2,169 | N/A | 5,250 | N/A |
| 9/30/2015 | 134,323 | 2,727 | N/A | 1,540 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 2352 ( 40.7% par an) est supérieure au taux d'épargne ( 1.3% ).
Bénéfices vs marché: Les bénéfices de 2352 ( 40.7% par an) devraient croître plus rapidement que le marché TW ( 24.9% par an).
Croissance élevée des bénéfices: Les bénéfices de 2352 devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de 2352 ( 4.5% par an) devrait croître plus lentement que le marché de TW ( 21.6% par an).
Croissance élevée des revenus: Le chiffre d'affaires de 2352 ( 4.5% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de 2352 devrait être élevé dans 3 ans
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/15 05:09 |
| Cours de l'action en fin de journée | 2026/09/15 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Qisda Corporation est couverte par 7 analystes. 2 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Changrong Chen | Capital Securities Corporation |
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |